NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) has 44 open-market insider trades by 14 insiders since 2012. The most active filer is Malcolm G. Witter, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| John K. Scott Jr. | 10% Owner | — | 5 | $8.2M | 2023-11-27 |
| Partners Value Arbitrage Fund Lp Platinum | 10% | — | 1 | $2.7M | 2012-10-10 |
| Mark Jerome Pykett | Dir | — | 5 | $279K | 2014-06-01 |
| Malcolm G. Witter | Dir | — | 6 | $163K | 2022-11-30 |
| Michael M. Goldberg | Pres | — | 1 | $108K | 2017-05-16 |
| Brendan A. Ford | Dir | — | 5 | $92K | 2015-07-31 |
| Gordon A. Troup | Dir | — | 4 | $90K | 2016-04-20 |
| Thomas H. Tulip | Chief Bus. Officer | — | 2 | $90K | 2015-03-26 |
| Brent L. Larson | CFOEVPTreas & Sec'y | — | 2 | $88K | 2015-12-01 |
| Jed Latkin | CEOCOO & CFO | — | 6 | $35K | 2020-08-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Malcolm G. Witter | Director | Buy | $32K | 2021-09-17 |
| Malcolm G. Witter | Director | Buy | $26K | 2021-07-26 |
| Malcolm G. Witter | Director | Buy | $16K | 2021-04-23 |
| Malcolm G. Witter | Director | Buy | $45K | 2021-03-29 |
| Malcolm G. Witter | Director | Buy | $35K | 2021-03-03 |
| Malcolm G. Witter | Director | Buy | $10K | 2020-12-28 |
Companies that share insiders with NAVB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John K. Scott Jr. | 10% | Buy | $25K | 2020-08-30 |
| Jed Latkin | CEO & COO & CFO | Buy | $5K | 2020-02-20 |
| John K. Scott Jr. | 10% Owner | Buy | $4.0M | 2020-02-13 |
| John K. Scott Jr. | 10% Owner | Buy | $1000K | 2019-12-06 |
| John K. Scott Jr. | 10% Owner | Buy | $3.0M | 2019-06-18 |
| Jed Latkin | CEO & COO & CFO | Buy | $1K | 2019-06-05 |
| Sarah Kathryn Rouan | Director | Buy | $5K | 2019-05-17 |
| Jed Latkin | CEO & COO & CFO | Buy | $4K | 2019-05-16 |
| Jed Latkin | CEO & COO & CFO | Buy | $10K | 2019-05-13 |